"10.1371_journal.pone.0053645","plos one","2013-01-08T00:00:00Z","Cristina Teixidó; Rosó Marés; Miguel Aracil; Santiago Ramón y Cajal; Javier Hernández-Losa","Molecular Pathology Group, Vall d’Hebron Research Institute, Universidad Autonoma of Barcelona, Barcelona, Spain; Pharmamar, Madrid, Spain; Pathology Department, Vall d’Hebron University Hospital, Universidad Autonoma of Barcelona, Barcelona, Spain","Conceived and designed the experiments: CT SRC JHL. Performed the experiments: CT RM. Analyzed the data: CT JHL. Contributed reagents/materials/analysis tools: CT RM MA SRC JHL. Wrote the paper: CT JHL.","Miguel Aracil is an employee for Pharmamar Company, which developed Elisidepsin. There are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Cristina Teixidó","CT",5,TRUE,3,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
